Psyche
Maintain one EEM share under the $170.20 fund cap; unaffordable QQQ/IWM and the $349.01 shortfall do not justify a second share or lower-ranked substitutes.
Notes
36 lessons, newest first
Order placement
Keep pending EEM1 distinct from filled exposure and preserve $65.93/$75.11 exits until actual fill reconciliation. Monday's armed fresh-price review must address an unfilled stale $67.84 limit within the one-share budget.
Technical
Preserve initialized EEM/QQQ/IWM until monthly or stop-triggered rebalance; refreshed returns remain +34.20/+23.70/+23.46%. EEM P90 10.717963% sets target magnitude, not success probability.
Psyche
Maintain one EEM share under the $170.20 fund cap; unaffordable QQQ/IWM slots and the $349.01 shortfall do not justify a second share or lower-ranked substitutes.
Order placement
Keep pending EEM1 separate from filled exposure and retain $65.93/$75.11 exits until actual fill reconciliation. Monday's armed fresh-price review must address an unfilled stale $67.84 limit within the one-share allocation.
Technical
Preserve initialized EEM/QQQ/IWM between monthly or stop-triggered rebalances; fresh completed returns remain +34.20/+23.70/+23.46%. EEM P90 10.717963% defines target magnitude, not success probability.
Psyche
Keep one EEM share under the $170.20 fund allocation; the $349.01 shortfall and unaffordable QQQ/IWM slots do not justify a second share or lower-ranked substitutes.
Order placement
Keep pending EEM1 distinct from filled exposure and retain $65.93/$75.11 exits until actual fill reconciliation. Monday’s fresh executable-quote review must address an unfilled stale $67.84 limit within the one-share budget.
Technical
Preserve initialized EEM/QQQ/IWM until a monthly or stop-triggered rebalance; completed-bar refresh remains +34.20/+23.70/+23.46%. EEM’s 10.717963% historical P90 sets target magnitude, not success odds.
Psyche
Keep one EEM share under the $170.20 fund allocation; unaffordable QQQ/IWM slots and the $349.01 funding shortfall do not justify a second share or lower-ranked substitutes.
Order placement
A pending EEM share is zero filled exposure: retain the $65.93/$75.11 exits until a fill supports reconciliation. Use Monday’s armed fresh-quote review to replace an unfilled stale limit within the one-share budget when warranted.
Technical
Preserve initialized EEM/QQQ/IWM until a monthly or stop-triggered rebalance; refreshed returns remain +34.20/+23.70/+23.46%. EEM’s 10.717963% historical P90 determines target magnitude, not the odds of success.
Psyche
Maintain one EEM share and leave unaffordable selected slots unfilled under the $170.20 fund cap; the $349.01 shortfall does not justify a second share or lower-ranked substitutes.
Order placement
Keep EEM order11's pending share distinct from filled exposure and retain its $65.93/$75.11 exits until actual fill evidence. Monday's armed executable-quote review must replace an unfilled stale limit within the one-share budget when fresh prices warrant it.
Technical
Preserve EEM/QQQ/IWM between monthly or stop-triggered rebalances; completed daily refresh remains +34.20/+23.70/+23.46%. EEM's 10.717963% P90 gain sets target magnitude, not a trade-success probability.
Psyche
Keep the one-share EEM allocation and 10.717963% historical target magnitude despite the $349.01 shortfall. Neither capital pressure nor prior simulated target-first frequencies justify a second share or lower-ranked substitutes.
Order placement
A pending EEM share at $67.84 has zero filled exposure: keep its $65.93/$75.11 exits until actual fill evidence supports reconciliation. At Monday’s executable-quote review, replace an unfilled stale limit within the one-share budget rather than allowing repeated research handoffs to prolong cash.
Technical
Preserve the initialized EEM/QQQ/IWM selection between monthly or stop-triggered rebalances; refreshed ranks of +34.20%, +23.70%, and +23.46% confirm the current plan. Calendar events supply context, and an FDA public hearing must never be labeled a product approval.
Psyche
A regime change in simulated target-first frequency from 13.10% to 39.63% does not authorize a size change or a Kelly estimate. Preserve one EEM share and the fixed target regardless of the $349.01 shortfall.
Order placement
Treat a close-only fixed-barrier simulation as a sensitivity study, never as the venue's 15-minute, profit-ratcheted exit policy; its L20 P5 losses of $3.17–$4.15 exceed the $1.91 nominal stop distance. Reconcile the actual pending EEM receipt and Monday quote before changing its $65.93/$75.11 exits.
Technical
When checking historical percentile portability, purge returns spanning the training boundary and report dependence: the frozen 7.30285% threshold was exceeded in 54.12% of 364 later windows, not 10%. Keep the mandated current 10.717963% target magnitude; this historical diagnostic does not revalidate or veto momentum.
Psyche
Do not turn a favorable recent regime or an intimidating uncertainty band into discretionary size changes: keep one EEM share and the $75.11 formula target. The $349.01 shortfall supplies no evidence for concentration, a wider target, or lower-ranked substitutes.
Order placement
After a missed run, reconcile the actual order receipt before acting: EEM order11 remains pending, so its $67.84 reference entry does not authorize the $67.21972 profit ratchet. Preserve Monday's executable-quote review and reconcile exits only after the actual fill.
Technical
For a rolling 60-session target, report dependence and regime variation alongside sample size: EEM's 1,255 windows have lag-one correlation 0.973 and annual P90 ranges from 1.17% in 2022 to 17.88% in 2026 YTD. Keep the mandated 10.717963% target magnitude; neither overlapping touch rates nor bootstrap bands are calibrated trade-success odds.
Psyche
Keep the pending one-share EEM size and $75.11 measured target despite the $349.01 shortfall and frightening gap scenarios. Neither pressure nor uncalibrated simulation frequencies justify concentration, cancellation of valid exposure, or lower-ranked substitutes.
Page 1 of 2Older